Just when you least expect it, big news comes to the surface. In the second paragraph of Extendicare’s fourth quarter and year-end earnings release, management slipped in the much-used statement that it has formed an independent committee of the board to “review and consider various structures and options that would provide value to shareholders,” or in other words, maximize shareholder value by getting the best price. Among the alternatives, of course, are a sale or reorganization of the company, or just part of the company. Lehman Brothers has been hired to be the company’s advisor to explore the alternatives.
Given the history of the company’s share price, the timing is a bit unusual. From mid-1999 through mid-2003, Extendicare’s share price was stuck in the $2.00 to $4.00 trading range. That was during the virtual collapse of the publicly traded skilled nursing company sector, and four years of basically no return to shareholders is a bit tough to swallow. But by the end of 2003, the stock closed at $10.20 per share, increased by 20% in 2004 and hit a high of $18.09 last year, closing the year at $15.63. The point is that for the past three years shareholders have been very pleased with the returns in what has otherwise been a rather dull stock market.
We have sung the praises of Extendicare’s turnaround in The SeniorCare Investor over the past two years, and prior to the most recent announcement, the company’s adjusted EBITDA multiple of 8.3x was very close to industry leader Manor Care, with an 8.5x multiple. But Extendicare’s shares soared by nearly 40% on the day of the release, putting Extendicare at the head of the class, at least for now. What we can’t figure out is, why now? The stock has been trading well, but the fourth quarter results were less than optimal, with earnings before taxes down from the fourth quarter in 2004, and with the results at newly acquired Assisted Living Concepts declining from the third quarter at a time when the assisted living industry is going like gangbusters. Valuations of seniors housing companies are at historic highs, but not nursing facility companies, even though private equity interest in the skilled nursing business seems to be growing.
Extendicare, however, presents a unique opportunity, for management, shareholders and potential buyers. Because in some ways it is really two companies, one with Canadian operations and the other (four times the size) with U.S. operations, the Canadian business could be sold to one group and the U.S. part to another, the Canadian business could be spun out into a new REIT, using Canada’s more liberal REIT regulations, or sold to another REIT, or any combination you could think of. And don’t forget the home health business, which has revenues of C$ 128 million.
Extendicare’s shares are now trading at more than $21 per share, and at these levels the acquisition premium appears to be already built in, which is what happened to Beverly Enterprises just about this time last year. Some Canadian analysts, however, believe the full value is between $24 and $27 per share. Unfortunately for their investing clients, we doubt they were saying this two weeks ago. But it is the split-up potential that has investors licking their chops, and crunching their numbers, as Canadian REITs tend to be valued differently, and the options for the U.S. portfolio include private equity players and, perhaps, a few operators, but probably not at $21 per share for those operators. We do not know if a major shareholder or two has prompted this decision, even though management has declared it to be one decided by the board without any outside pressure. Now, one has to wonder if those private equity firms are crunching the numbers for Genesis Healthcare and Kindred Healthcare. It may be an interesting year for the skilled nursing sector after all.
Related links:
Extendicare
For more articles on the senior care acquisition market, see Index links for The SeniorCare Investor
Get the inside scoop on senior care M&A at The SeniorCare Investor
Database of health care M&A transactions, including senior care acquisitions